Publications
2 shownCeritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer
Ceritinib was highly active in patients with advanced, ALK-rearranged NSCLC, including those who had had disease progression during crizotinib treatment, regardless of the prese...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,743
- Institution
- Genome Institute of Singapore
External Links
Identifiers
- ORCID
- 0000-0002-6514-6786
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.